Physician profile
Marc Frager
NPI 1740394220
$1,749.97
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $572 · 2020: $759 · 2021: $419.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $400.39 | 2019-2021 | |
| Lilly USA, LLC | $369.70 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $205.26 | 2019-2021 | |
| Abbvie INC. | $142.96 | 2019-2021 | |
| Novo Nordisk INC | $117.46 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $70.62 | 2020 | |
| Insulet Corporation | $55.50 | 2019-2021 | |
| Horizon Therapeutics Plc | $39.64 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.05 | 2020 | |
| Amneal Pharmaceuticals LLC | $37.99 | 2019-2021 | |
| Shire North American Group INC | $35.38 | 2019 | |
| Xeris Pharmaceuticals, INC. | $32.49 | 2020-2021 | |
| Amgen INC. | $32.48 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $30.58 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.20 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lifescan, INC. | $22.17 | 2021 | |
| Recordati_rare_diseases_inc. | $20.32 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $19.33 | 2021 | |
| Companion Medical, INC. | $18.55 | 2020 | |
| Medtronic, INC. | $17.73 | 2021 | |
| Ibsa Pharma INC. | $15.17 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Frager listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.